Health Wildcatters’ next speaker at The Pulse Healthcare Innovation Breakfast Series will explore how to bring clinical research into the 21st century.
The Oct. 5 event will feature Dr. Brad Hirsch, CEO of SignalPath, a clinical research company that leverages technology to make clinical trials more efficient and effective. In addition to leading SignalPath, Hirsch is a practicing medical oncologist at Texas Oncology and serves as a special advisor to Highlander Partners, a Dallas-based private equity fund. He previously was the senior medical director for Flatiron Health, a data and analytics company in oncology valued at over $1 billion, and a faculty member at Duke University.
Networking for the Oct. 5 program will begin at 7:30 a.m., with Hirsch taking the stage at 8 a.m., at Health Wildcatters’ office, located on the 20th floor of 1910 Pacific Ave. in downtown Dallas. Coffee and a continental breakfast will be provided.
The Pulse Healthcare Innovation Breakfast Series aims to connect entrepreneurs, medical professionals, and innovators in the healthcare and business communities of Dallas-Fort Worth.
For more information and for tickets, click here.